Literature DB >> 34717063

Hepatic Stellate Cell: A Double-Edged Sword in the Liver.

Nianan Luo1, Jiangbin Li, Yu Wei, Jianguo Lu, Rui Dong.   

Abstract

Hepatic stellate cells (HSCs) are located in the space of Disse, between liver sinusoidal endothelia cells (LSECs) and hepatocytes. They have surprised and excited hepatologists for their biological characteristics. Under physiological quiescent conditions, HSCs are the major vitamin A-storing cells of the liver, playing crucial roles in the liver development, regeneration, and tissue homeostasis. Upon injury-induced activation, HSCs convert to a pro-fibrotic state, producing the excessive extracellular matrix (ECM) and promoting angiogenesis in the liver fibrogenesis. Activated HSCs significantly contribute to liver fibrosis progression and inactivated HSCs are key to liver fibrosis regression. In this review, we summarize the comprehensive understanding of HSCs features, including their roles in normal liver and liver fibrosis in hopes of advancing the development of emerging diagnosis and treatment for hepatic fibrosis.

Entities:  

Mesh:

Year:  2021        PMID: 34717063      PMCID: PMC8815467          DOI: 10.33549/physiolres.934755

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  60 in total

Review 1.  Hepatic immune regulation by stromal cells.

Authors:  Frank A Schildberg; Arlene H Sharpe; Shannon J Turley
Journal:  Curr Opin Immunol       Date:  2014-10-28       Impact factor: 7.486

2.  Correction to: A novel role of glutathione S-transferase A3 in inhibiting hepatic stellate cell activation and rat hepatic fibrosis.

Authors:  Haihua Chen; Qixin Gan; Congying Yang; Xiongqun Peng; Jiao Qin; Sisi Qiu; Yanzhi Jiang; Sha Tu; Ying He; Shenglan Li; Huixiang Yang; Lijian Tao; Yu Peng
Journal:  J Transl Med       Date:  2020-04-30       Impact factor: 5.531

Review 3.  Tumor regulation of the tissue environment in the liver.

Authors:  Tobias Eggert; Tim F Greten
Journal:  Pharmacol Ther       Date:  2017-02-04       Impact factor: 12.310

4.  Proteomic Profiling of Human Hepatic Stellate Cell Line LX2 Responses to Irradiation and TGF-β1.

Authors:  Baoying Yuan; Yuhan Chen; Zhifeng Wu; Li Zhang; Yuan Zhuang; Xiaomei Zhao; Hao Niu; Jason Chia-Hsien Cheng; Zhaochong Zeng
Journal:  J Proteome Res       Date:  2018-12-10       Impact factor: 4.466

Review 5.  Pathogenesis of liver cirrhosis.

Authors:  Wen-Ce Zhou; Quan-Bao Zhang; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

6.  Exosomes derived from natural killer cells inhibit hepatic stellate cell activation and liver fibrosis.

Authors:  Ling Wang; Yinghao Wang; Jun Quan
Journal:  Hum Cell       Date:  2020-05-24       Impact factor: 4.174

Review 7.  Hepatic stellate cells: central modulators of hepatic carcinogenesis.

Authors:  Alexandra I Thompson; Kylie P Conroy; Neil C Henderson
Journal:  BMC Gastroenterol       Date:  2015-05-27       Impact factor: 3.067

Review 8.  Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets.

Authors:  Chong-Yang Zhang; Wei-Gang Yuan; Pei He; Jia-Hui Lei; Chun-Xu Wang
Journal:  World J Gastroenterol       Date:  2016-12-28       Impact factor: 5.742

9.  MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression.

Authors:  Qi Wang; Song Wei; Haoming Zhou; Lei Li; Shun Zhou; Chengyu Shi; Yong Shi; Jiannan Qiu; Ling Lu
Journal:  Front Cell Dev Biol       Date:  2020-06-19

10.  Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis.

Authors:  Céline Hoffmann; Nour El Houda Djerir; Anne Danckaert; Julien Fernandes; Pascal Roux; Christine Charrueau; Anne-Marie Lachagès; Frédéric Charlotte; Isabelle Brocheriou; Karine Clément; Judith Aron-Wisnewsky; Fabienne Foufelle; Vlad Ratziu; Bernard Hainque; Dominique Bonnefont-Rousselot; Pascal Bigey; Virginie Escriou
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

View more
  2 in total

1.  Enrichment Methods for Murine Liver Non-Parenchymal Cells Differentially Affect Their Immunophenotype and Responsiveness towards Stimulation.

Authors:  Carolina Medina-Montano; Maximiliano Luis Cacicedo; Malin Svensson; Maria Jose Limeres; Yanira Zeyn; Jean Emiro Chaves-Giraldo; Nadine Röhrig; Stephan Grabbe; Stephan Gehring; Matthias Bros
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

2.  Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy.

Authors:  Yan Lin; Mengchao Yan; Zhongtian Bai; Ye Xie; Longfei Ren; Jiayun Wei; Dan Zhu; Haiping Wang; Yonggang Liu; Junqian Luo; Xun Li
Journal:  J Nanobiotechnology       Date:  2022-10-01       Impact factor: 9.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.